Mediclinic International PLC (MDCM.L)
MDCM.L on London Stock Exchange
326.50GBp
20 Feb 2019
326.50GBp
20 Feb 2019
Change (% chg)
-- (--)
-- (--)
Prev Close
326.50
326.50
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
2,018,450
2,018,450
52-wk High
712.40
712.40
52-wk Low
293.10
293.10
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2019 | Sep | 1,387.00 | -0.228 |
| FY 2018 | Mar '18 | 1,465.00 | -0.600 |
| Sep | 1,405.00 | -0.068 | |
| FY 2017 | Mar '17 | 1,466.00 | 0.161 |
| Sep | 1,283.00 | 0.149 |
*Note: Units in Millions ofBritish Pounds
**Note: Units in British Pounds
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Year Ending Mar-19 | 12 | 2,933.21 | 2,999.00 | 2,863.80 | 2,916.39 |
| Year Ending Mar-20 | 12 | 3,075.72 | 3,257.00 | 2,926.50 | 3,076.48 |
| Earnings (per share) | |||||
| Year Ending Mar-19 | 13 | 26.36 | 30.16 | 24.00 | 32.39 |
| Year Ending Mar-20 | 13 | 29.49 | 36.46 | 26.39 | 35.08 |
| LT Growth Rate (%) | 2 | 4.77 | 10.40 | -0.86 | 6.97 |
Sales and Profit Figures in British Pound (GBP);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | 22.09 | 27.00 | 33.70 | |
| P/E High - Last 5 Yrs. | -- | 109.75 | 49.87 | |
| P/E Low - Last 5 Yrs. | -- | 20.15 | 24.25 | |
| Beta | 1.03 | 0.61 | 0.90 | |
| Price to Sales (TTM) | 1.84 | 18.12 | 6.29 | |
| Price to Book (MRQ) | 1.24 | 4.00 | 5.26 | |
| Price to Tangible Book (MRQ) | 2.62 | 4.48 | 6.77 | |
| Price to Cash Flow (TTM) | 13.03 | 16.00 | 24.98 | |
| % Owned Institutions | -- | 7.47 | 1.69 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 1.03 | 1.40 | |
| Dividend Yield - 5 Year Avg | -- | 0.80 | 1.42 | |
| Dividend 5 Year Growth Rate | -- | 10.12 | 4.85 | |
| Payout Ratio(TTM) | 25.43 | 13.65 | 41.03 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 33.64 | 11.26 | 12.75 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 30.47 | 10.00 | 5.84 | |
| Sales - 5 Yr. Growth Rate | -- | 15.43 | 11.23 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 29.83 | 56.33 | 47.15 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 4.44 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 10.43 | 10.85 | |
| Capital Spending - 5 Yr. Growth Rate | -- | 24.93 | 15.20 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | 1.66 | 9.38 | 2.25 |
| Current Ratio (MRQ) | 1.81 | 9.68 | 3.08 |
| LT Debt to Equity (MRQ) | 47.99 | 48.59 | 11.38 |
| Total Debt to Equity (MRQ) | 49.68 | 61.02 | 16.12 |
| Interest Coverage (TTM) | 6.42 | 33.00 | 29.47 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 38.30 | 39.82 | 53.81 | |
| Gross Margin - 5 Yr. Avg. | -- | 40.93 | 52.18 | |
| EBITD Margin (TTM) | 18.52 | -- | -- | |
| EBITD - 5 Yr. Avg | -- | -0.48 | 12.87 | |
| Operating Margin (TTM) | 13.17 | -3.63 | 6.20 | |
| Operating Margin - 5 Yr. Avg. | -- | -11.52 | 8.31 | |
| Pre-Tax Margin (TTM) | 11.17 | 5.98 | 7.16 | |
| Pre-Tax Margin - 5 Yr. Avg. | -- | -0.66 | 8.61 | |
| Net Profit Margin (TTM) | 8.84 | 3.18 | 3.30 | |
| Net Profit Margin - 5 Yr. Avg. | -- | -3.24 | 4.89 | |
| Effective Tax Rate (TTM) | 20.85 | 19.39 | 22.91 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 37.01 | 23.38 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 93,364 | 6,814,693 | 842,398,385 | |
| Net Income/Employee (TTM) | 8,253 | -999,232 | 99,842,801 | |
| Receivable Turnover (TTM) | -- | 7.95 | 5.71 | |
| Inventory Turnover (TTM) | -- | 66.99 | 3.47 | |
| Asset Turnover (TTM) | -- | 0.60 | 0.93 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -- | 5.14 | 11.06 | |
| Return on Assets - 5 Yr. Avg. | -- | 5.87 | 12.20 | |
| Return on Investment (TTM) | -- | 6.65 | 14.45 | |
| Return on Investment - 5 Yr. Avg. | -- | 7.45 | 15.87 | |
| Return on Equity (TTM) | -- | 10.51 | 15.96 | |
| Return on Equity - 5 Yr. Avg. | -- | 11.19 | 17.00 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | 30.47 | -- | -- |
| EPS (TTM) % | 5.16 | -- | -- |
| Dividend % | 0.00 | -- | -- |
Note: Units in Millions of US Dollars
Performance for Mediclinic International PLC
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | -8.41 | -10.29 | 54 | 28 |
| 13 Week | -6.16 | -8.59 | 99 | 34 |
| 26 Week | -1.93 | -4.73 | 99 | 19 |
| 52 Week | -22.83 | -28.81 | 78 | 12 |
| YTD | -11.02 | -16.52 | 99 | 11 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 39.08% |
| # of Holders: | 238 |
| Total Shares Held: | 288,105,107 |
| 3 Mo. Net Change: | -11,322,750 |
| # New Positions: | 12 |
| # Closed Positions: | 47 |
| # Increased Positions: | 29 |
| # Reduced Positions: | 82 |
| # Net Buyers: | -53 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.